Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10058045HBVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS10058044HBVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30008701HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30008702HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30061613HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30061614HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS44019305HTLV-1ENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS44019306HTLV-1ENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS44004779HTLV-1ENSG00000164305.20protein_codingCASP3NoNo836P42574
TCGA Plot Options
Drug Information
GeneCASP3
DrugBank IDDB12709
Drug NameTributyrin
Target IDBE0001162
UniProt IDP42574
Regulation Typeactivator
PubMed IDs11485828
CitationsClarke KO, Feinman R, Harrison LE: Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3. Cancer Lett. 2001 Sep 28;171(1):57-65. doi: 10.1016/s0304-3835(01)00574-2.
GroupsInvestigational
Direct ClassificationTriacylglycerols
SMILESCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC
Pathways
PharmGKB
ChEMBLCHEMBL118722